296 HER2-specific highly scalable CAR NK cell (anti-HER2-CAR SNK02) exhibits a significantly enhanced antitumor activity against HER2-expressing tumors as an off-the-shelf allogeneic immune cell therapy

• Yong Man Kim,
• Minji Kim,
• Yong-hee Rhee,
• Hee-Sung Chae,
• Seo-Gu Kang,
• Joungmin Lee,
• Yoon Mi Kang,
• Jae Seob Jung,
• Paul Y Song,
• Minchan Gil

Affiliations

Yong Man Kim

6 Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Minji Kim

1Mayo Clinic, Jacksonville, FL, USA

Yong-hee Rhee

1NKMAX Co., Ltd., Seongnam, Gyeonggi-do, Republic of Korea

Hee-Sung Chae

1NKMAX Co., Ltd., Seongnam, Gyeonggi-do, Republic of Korea

Seo-Gu Kang

1NKMAX Co., Ltd., Seongnam, Gyeonggi-do, Republic of Korea

Joungmin Lee

1NKMAX Co., Ltd., Seongnam, Gyeonggi-do, Republic of Korea

Yoon Mi Kang

2NKGenbiotech, Inc., Santa Ana, CA, USA

Jae Seob Jung

1NKMAX Co., Ltd., Seongnam, Gyeonggi-do, Republic of Korea

Paul Y Song

2NKGenbiotech, Inc., Santa Ana, CA, USA

Minchan Gil

1NKMAX Co., Ltd., Seongnam, Gyeonggi-do, Republic of Korea